![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/138 | (2006.01) |
A61K 31/138 | (2013.01) | ||
A61K 31/439 | (2006.01) | ||
A61K 31/439 | (2013.01) | ||
A61K 31/58 | (2006.01) | ||
A61K 31/58 | (2013.01) | ||
A61P 11/06 | (2006.01) | ||
A61P 11/00 | (2018.01) | ||
A61P 11/00 | (2006.01) | ||
A61P 11/06 | (2018.01) | ||
A61K 9/00 | (2006.01) | ||
A61P 43/00 | (2018.01) | ||
A61K 9/0075 | (2013.01) |
(11) | Number of the document | 3650019 |
(13) | Kind of document | T |
(96) | European patent application number | 19214674.4 |
Date of filing the European patent application | 2015-05-27 | |
(97) | Date of publication of the European application | 2020-05-13 |
(45) | Date of publication and mention of the grant of the patent | 2023-09-06 |
(46) | Date of publication of the claims translation |
(30) | Number | Date | Country code |
201462003764 P | 2014-05-28 | US | |
201462004304 P | 2014-05-29 | US | |
201462042506 P | 2014-08-27 | US |
(72) |
BARNES, Neil Christopher , GB
PASCOE, Steven John , US
|
(73) |
GlaxoSmithKline Intellectual Property Development
Limited ,
GSK Medicines Research Centre
Gunnels Wood Road, Stevenage SG1 2NY,
GB
|
(54) | FLUTICASONE FUROATE IN THE TREATMENT OF COPD |
FLUTICASONE FUROATE IN THE TREATMENT OF COPD |